2-191836682-T-C
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_004657.6(CAVIN2):c.519A>G(p.Lys173Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0042 in 1,613,768 control chromosomes in the GnomAD database, including 242 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.023 ( 121 hom., cov: 32)
Exomes 𝑓: 0.0023 ( 121 hom. )
Consequence
CAVIN2
NM_004657.6 synonymous
NM_004657.6 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.433
Genes affected
CAVIN2 (HGNC:10690): (caveolae associated protein 2) This gene encodes a calcium-independent phospholipid-binding protein whose expression increases in serum-starved cells. This protein is a substrate for protein kinase C (PKC) phosphorylation and recruits polymerase I and transcript release factor (PTRF) to caveolae. Removal of this protein causes caveolae loss and its over-expression results in caveolae deformation and membrane tubulation.[provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.61).
BP6
Variant 2-191836682-T-C is Benign according to our data. Variant chr2-191836682-T-C is described in ClinVar as [Benign]. Clinvar id is 782418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.433 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0772 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0227 AC: 3460AN: 152132Hom.: 122 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
3460
AN:
152132
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.00570 AC: 1425AN: 249852 AF XY: 0.00429 show subpopulations
GnomAD2 exomes
AF:
AC:
1425
AN:
249852
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00226 AC: 3303AN: 1461518Hom.: 121 Cov.: 33 AF XY: 0.00191 AC XY: 1386AN XY: 727026 show subpopulations
GnomAD4 exome
AF:
AC:
3303
AN:
1461518
Hom.:
Cov.:
33
AF XY:
AC XY:
1386
AN XY:
727026
Gnomad4 AFR exome
AF:
AC:
2682
AN:
33462
Gnomad4 AMR exome
AF:
AC:
154
AN:
44690
Gnomad4 ASJ exome
AF:
AC:
0
AN:
26126
Gnomad4 EAS exome
AF:
AC:
0
AN:
39694
Gnomad4 SAS exome
AF:
AC:
14
AN:
86232
Gnomad4 FIN exome
AF:
AC:
0
AN:
53374
Gnomad4 NFE exome
AF:
AC:
131
AN:
1111786
Gnomad4 Remaining exome
AF:
AC:
307
AN:
60388
Heterozygous variant carriers
0
161
322
483
644
805
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0228 AC: 3467AN: 152250Hom.: 121 Cov.: 32 AF XY: 0.0224 AC XY: 1668AN XY: 74456 show subpopulations
GnomAD4 genome
AF:
AC:
3467
AN:
152250
Hom.:
Cov.:
32
AF XY:
AC XY:
1668
AN XY:
74456
Gnomad4 AFR
AF:
AC:
0.0794174
AN:
0.0794174
Gnomad4 AMR
AF:
AC:
0.00765106
AN:
0.00765106
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0.000207125
AN:
0.000207125
Gnomad4 FIN
AF:
AC:
0
AN:
0
Gnomad4 NFE
AF:
AC:
0.000235273
AN:
0.000235273
Gnomad4 OTH
AF:
AC:
0.0160985
AN:
0.0160985
Heterozygous variant carriers
0
164
328
491
655
819
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
34
68
102
136
170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
12
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Jun 21, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Mutation Taster
=100/0
polymorphism (auto)
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at